NIH Receives Glimmer of Hope as AHRQ Inches Closer to Elimination
The House and Senate appropriations committees earlier this week passed parallel spending bills that would boost NIH budgets while eliminating the Agency for Healthcare Research Quality, a $465 million agency that plays a central role in the implementation of President Barack Obama’s health care law.
After more than a decade of flat funding and budget cuts, both bills provided aggressive increases for NIH:
• The House appropriations committee approved a proposed $1.1 billion increase on June 24.
• Senate subcommittee appropriators went even further, proposing a $2 billion increase during markup June 23.
ASCO Publishes Drug Value Assessment Tool
The American Society of Clinical Oncology earlier this week published a proposed framework for assessing the value of new cancer treatments.
The paper, published in the Journal of Clinical Oncology June 22, quantifies clinical benefit, side effects and cost as components of value.
ASCO’s objective is to build a standardized tool that can be used as the basis of shared decision-making by oncologists and their patients.
OHSU Reaches $1 Billion Goal, Begins Recruiting Scientists and Researchers
Oregon Health & Science University met the challenge posed by Nike co-founder Phil Knight and his wife Penny by raising $500 million in less than two years, earning the Knights’ matching gift and setting a $1 billion fundraising record. The announcement was made June 25.
The $1 billion will support the first large-scale program dedicated to early detection of lethal cancers. OHSU Knight Cancer Institute will now begin rapid recruitment of about 25 of top-tier researchers.
|Appropriations Bill Seeks to Preempt FDA Efforts to Broaden Tobacco Regulation|
A $20.65 billion agriculture appropriations bill, which cleared a House subcommittee June 18, seeks to limit FDA’s ability to review electronic cigarettes, cigars and other tobacco products already on the market.
The legislation—which was approved by the House Appropriations Subcommittee on Rural Development, Food and Drug Administration and Related Agencies—would prevent the FDA Center for Tobacco Products from requiring products already on the market to go through the Premarket Tobacco Review application process under the Federal Food, Drug and Cosmetic Act.
|Study: Widespread Overtreatment Of Benign Lung Nodules in Community Oncology Practices|
Thousands of U.S. patients may be undergoing unnecessary lung biopsies and surgeries annually due to overtreatment of benign lung nodules, according to a study published in the journal CHEST.
The study—funded by Integrated Diagnostics, or Indi—examined how community pulmonologists treated and managed the care of 377 patients with indeterminate (medium-sized) lung nodules. The paper is titled “Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.”
AACR Launches Grant Program For Young Investigators
The American Association for Cancer Research has launched the AACR NextGen Grants for Transformative Cancer Research, a funding initiative to stimulate innovative research from young investigators.
The grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that, because of its very nature, may not otherwise be funded through existing channels.
Five new members appointed to NCAB
Five members rotate off the NCI Board of Scientific Advisors
AHRQ to fund three centers of excellence with $52 million over five years
Maurizio D’Incalci receives award from European Association of Cancer Research, AACR, and Italian Cancer Society
Conquer Cancer Foundation honors six oncology practices with Clinical Trials Participation Awards
Broad Institute to collaborate with Google Genomics
- Guardant Health partners with SWOG for NSCLC study
Karmanos Cancer Institute and Detroit Tigers to host “Pink Out the Park”
| ||Drugs and Targets|
FDA grants priority review to MM-398
Soligenix to recruit patients for phase III study
- Advaxis submits special protocol assessment to FDA
Amgen and Roche to collaborate on phase Ib study
Cigna publishes positive coverage decision for VeriStrat